ORADE Grants Are Back!

The mandate of the Ontario Rheumatology Association Development and Education Committee (ORADE) is to support ORA members and AHP colleagues in their professional development by offering educational grants.  Following a 2-year pause due […]

Read More…


New Biosimilar Fact Sheet Now Available!

The ORA Government Affairs Committee have created a useful tool that organizes biosimilars and their various features, including formulations and LU Codes. You may find the new resource here: Biosimilars […]

Read More…


Sad News About the Passing of Dr. Vincent Mak

A message from ORA President, Dr. Felix Leung: It is with great difficulty that I must inform you of the sudden passing of our friend and colleague, Dr. Vincent Mak, on Wednesday, August […]

Read More…


Diversity, Equity and Inclusion Within the ORA

The ORA leadership team recently developed a Diversity, Equity and Inclusion statement that was approved by the Board of Directors. We invite you to scroll down to the bottom of our homepage to […]

Read More…


Updated ORA Position Statement: Biosimilar Switching

The ORA has recently updated its position statement on biosimilar switching. It is available here: Updated ORA Position Statement Biosimilar Switching […]

Read More…


Greetings From the New ORA President!

Greetings! I’d like to introduce myself to you as the new President of the Ontario Rheumatology Association. I am very excited to be leading such an important professional association! I have been with […]

Read More…


Drug Shortages Update – Message from the Canadian Rheumatology Association

  The Canadian Rheumatology Association (CRA) has been recently notified by members across the country of shortages in certain medications that are integral to patient care. The CRA has previously responded to alerts […]

Read More…


Lancet Study: Vaccine Effectiveness Amongst Ontario Patients With Immune-Mediated Inflammatory Diseases

The full article is available here: The Lancet Rheumatology […]

Read More…


Ontario Science Table Guidelines for COVID Treatments & Other Important Links

Please note the following important links: Ontario Science Table Guidelines for COVID Treatments: https://covid19-sciencetable.ca/sciencebrief/clinical-practice-guideline-summary-recommended-drugs-and-biologics-in-adult-patients-with-covid-19-version-10-0/ COVID Assessment Centres: https://covid-19.ontario.ca/covid-19-test-and-testing-location-information#getting-a-clinical-assessment List of Sites Distributing Paxlovid: List of sites distributing Paxlovid – 2022-02-14 (2) […]

Read More…


Actemra (Tocilizumab) Update

Please see the most up to date information on Actemra shortages: Actemra Update […]

Read More…